Michael Carulli - 03 Mar 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMVP	Employee Stock Option (right to buy)	Award	$0	+265,000		$0.000000	265,000	03 Mar 2025	Common Stock	265,000	$1.32	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.